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Based on the authors’ data, one
would predict that RAG complexes
associate with bulk cellular chromatin
in a tissue-specific fashion (e.g., with
IgH but not TCR gene segments in
pro-B cells) and will not be brought
down with chromatin displaying re-
pressive marks (e.g., H3K9me3). Fu-
ture studies should also address
whether the transcriptional function of
promoters is required for recombinase
accessibility above and beyond pro-
moter-directed H3K4 methylation. As
the authors point out, the link between
H3K4me3 and RAG suggests at face
value that recombinase may be tar-
geted to almost any active gene in pre-
cursor lymphocytes. Clearly this is not
the case. An obvious source of addi-
tional specificity is the RSS, which is
bound by RAG1 and may synergize
with RAG2-H3K4me3 interactions to
generate a productive recombinase-
RSS complex. Alternatively, additional
chromatin modifications may contrib-
ute to a ‘‘histone code’’ for recombi-
nase targeting.
Lastly, Liu et al. (2007) show that
a PHD point mutation in the noncore
region of RAG2 (W453A) abrogates
DH/JH recombination in pro-B cells.
These data are in seeming contra-
diction with prior studies showing
that core RAG2, which lacks the entire
C terminus including the PHD, medi-
ates a normal degree of DH/JH
recombination but is defective for
VH/DHJH rearrangement. The au-
thors propose a highly testable model
to explain this apparent discrepancy.
They hypothesize that other parts of
the noncore RAG2 region impose an
inhibitory function on recombinase
that is counteracted by PHD bind-
ing to H3K4me3-marked chromatin. In
this model, the PHD mutation would
fail to relieve inhibition by the non-
core module, and recombination of
chromatinized substrates would be
blocked. In contrast, loss of the entire
RAG2 C terminus would generate an
active recombinase capable of rear-
ranging proximal (DH/JH) but per-
haps not distant (VH/DHJH) gene
segments. The latter, less efficient pro-
cess may benefit from the additional
punch provided by PHD-H3K4me3 in-
teractions. Notwithstanding, Liu et al.
(2007) have contributed an important
step in our quest to understand how
genetic elements coordinate the dy-
namic changes in transcription and
chromatin that drive stepwise as-
sembly of antigen receptor genes to
diversify our adaptive immune reper-
toire.
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Phagocytosis is a complex process that involvesmultiple cellular functions. In this issue of Immunity,
Silva et al. (2007) report that a protein ubiquitylation complex and the proteasome are required for the
clearance of apoptotic cells in Drosophila.Thedenomination ‘‘phagocyte’’ comes
from the Greek phagein—to eat—
and kytos—cell—and was coined by
Metchnikoff (and Claus) when he dis-
covered phagocytosis while investi-gating digestion in the starfish larva.
This mechanism is evolutionary very
ancient; it was possibly selected prior
to the invention of multicellularity by
early eukaryotic cells to ingest nutri-Immunity 2ents. Indeed, amoeba such asDictyos-
telium discoideum feed on microor-
ganisms, some of which have evolved
strategies to elude or hamper phago-
cytosis. As a result, it is likely that7, October 2007 ª2007 Elsevier Inc. 541
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measures todealwith suchpathogens.
Thus, a link with immunity is possibly
already present in unicellular eucary-
otes. As initially discovered by Metch-
nikoff, phagocytosis plays an essential
role in host defense in higher eucary-
otes. Phagocytosis also fulfills other
essential functions like homeostasis in
multicellular organisms and morpho-
genesisduringdevelopmentbydispos-
ing of cells undergoing programmed
cell death or necrosis. This phenome-
non concerns relatively few cells in
simple organisms such as the nema-
tode Caenorhabditis elegans in which
bystander neighboring cells quickly
engulf cells as soon as they have
implemented programmed cell death
(PCD) (Yu et al., 2006, and references
therein). Indeed, engulfment promotes
apoptosis in this model organism. By
contrast, PCD is quantitatively much
more important in other organisms, for
example in Drosophila melanogaster,
where many neurons are eliminated
during the maturation of the central
nervous system (CNS), or in mammals,
where up to 1010 cells are disposed of
every day. As a result, phagocytosis
is often performed by professional
phagocytes such as macrophages, al-
though other cells such as glial cells
may also be involved in this function
in the CNS. The challenge is to prevent
corpses from releasing cytotoxicmole-
cules or from inducing an excessive
inflammatory reaction. A failure to
achieve a rapidclearanceof effete cells
may result inautoimmunediseasesuch
as systemic lupus erythematosus in
humans or improper formation of the
CNS in Drosophila. In this issue of
Immunity, Silva et al. (2007) cast a new
light on the regulation of engulfment
of dying cells. They report that the
ubiquitin-proteasome machinery for
protein degradation is required for the
efficient clearance of apoptotic cells
in Drosophila.
The term phagocytosis encom-
passes distinct forms of engulfment
depending on the nature of the in-
gested particle and that of the phago-
cyte. There are, however, common
steps in this complex multistage pro-
cess. An initial step of recognition
mediated by receptors triggers intra-
cellular signaling to recruit additional542 Immunity 27, October 2007 ª2007 Emembranematerial and the actin cyto-
skeleton needed to form engulfing
pseudopods. Internalization then en-
sues and leads to the formation of a
phagosomal vacuole that fuses with
early endosomes during maturation
and ultimately fuses with lysosomes
to form phagolysosome. Phagosome
maturation is accompanied by acidifi-
cation of the vacuole. Hydrolytic en-
zymes delivered by vesicle fusion
degrade the phagosome contents. In
professional phagocytes, microbe kill-
ing is also achieved by the release of
antimicrobial peptides, reactive oxy-
gen, and nitrogen species.
Decades of study of phagocytosis
led to the concept of ‘‘elegant com-
plexity’’ mirrored in the identification
of multiple receptors, opsonins, and
signaling pathways (Stuart and Ezeko-
witz, 2005). Genetic model organisms
offer an approach to dissect this com-
plexity by highlighting the components
required for this process. A limitation
that should be kept in mind, however,
is that mutations affecting genes that
are also required in other functions
may lead to other phenotypes that po-
tentially mask their role in phagocyto-
sis. The clearance of apoptotic corp-
ses has been investigated extensively
inC. elegans, and its failure leads to the
persistence of cellular corpses. Stud-
ies have delineated two distinct path-
ways that act in partially redundant
mechanisms (Yu et al., 2006, and ref-
erences therein). The CED (cell death
abnormal) genes CED-2 (CrkII), CED-
12 (ELMO), and CED-5 (DOCK180)
act downstream of the MIG-2 (RhoG)
GTPase and its associated activator
UNC-73 (TRIO). They activate CED-10
(Rac), which controls actin remodelling
for pseudopodextension. The receptor
that triggers this conserved pathway
has not been identified in the worm,
although the ortholog of the phosphati-
dylserine receptor (PSR) may play a
minor role in this pathway. It has been
proposed that the second pathway
promotes vesicle recruitment and fu-
sion to maturing phagosomes and to
extending pseudopodsby focal exocy-
tosis (Yu et al., 2006). This pathway
uses the CED-1 receptor and the CED-
7 ATP-binding cassette transporter,
which is perhaps required to promote
phosphatidyl serine exposure on thelsevier Inc.outer membrane of both engulfed and
dying cells. The CED-6 (GULP) adaptor
functions downstream of CED-10 and
upstream of dynamin. CED-10 may
also mediate the action of the CED-1
pathway on cytoskeletal reorganiza-
tion. By contrast, our understanding of
apoptotic cell clearance in Drosophila
is less extensive. One receptor of the
CD36 family, Croquemort, has been
shown to be required for effete cell en-
gulfment by macrophages during em-
bryogenesis (Franc et al., 1999), but
surprisingly does not appear to be nec-
essary in a cell culture system (Manaka
et al., 2004). In the absence of apopto-
tic cells, Croquemort is much less ex-
pressed in embryonic macrophages.
Another receptor, Draper, is required
for clearance of corpses in macro-
phages and glial cells (Manaka et al.,
2004). This CED-1-related protein, to-
getherwithDmelCED-6, isalso required
in glial cells for disposal of pruned or
severed axons. The nature of the ‘‘eat
me’’ signals displayedbycells initiating
PCD remains elusive and does not
involve phosphatidylserine, at least in
cell culture experiments (Manaka et al.,
2004).
Silva et al. have embarked on a pro-
gram of forward genetics to further
identify genes involved in apoptotic
cell clearance (Silva et al., 2007). To
this end, they screened a collection
of lines carrying large genetic deletions
that collectively uncover most of the
Drosophila genome. A quarter of the
embryos laid by flies of a given line
are homozygous for one deficiency. It
is relatively straightforward to identify
lines in which clearance does not take
place by identifying the pattern of
apoptotic cells stained by acridine or-
ange. Nonphagocytosed corpses are
not clustered within macrophages
and thus appear dispersed throughout
the embryo. In this way, it is possible
to screen a large number of genes
rapidly. One limitation is that gene
products can be supplied by the het-
erozygous mother in the egg prior to
fertilization and may provide (in some
cases) enough function to compen-
sate a zygotic defect. Once an inter-
esting genetic deficiency has been
identified, smaller deletions and mu-
tants in the region are then tested.
Thus, a P element transposon inserted
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genes displayed the phenotype found
in a larger deletion, a decreased num-
ber of engulfed corpses per macro-
phage.CG3654was an obvious candi-
date because it encodes a fly ortholog
of PSR. However, it is the neighboring
gene CG3428, which is also affected
by the insertion, that causes the phe-
notype. The expression of a wild-type
CG3428 transgene in macrophages
is sufficient to rescue the apoptotic
clearance phenotype to aCG3428mu-
tant. CG3428, also called pallbearer
(pall), encodes an F box protein. F box
proteins are thought to provide speci-
ficity to SCF (Skp-cullin-F box) E3 li-
gase complexes that form part of the
ubiquitinylation machinery. Silva et al.
(2007) went on to identify SkpA and
Cul1 (LIN19) as components of the
PALL-SCF complex, which is thus dis-
tinct from the SLIMB-SCF complex
that negatively regulates an immune
signaling pathway in Drosophila. Mu-
tations in the genes encoding the E2
conjugating enzyme Effete (UbcD1)
and dominant suppressor mutations
for two proteasome subunits genes
display the pall mutant phenotype
and also interact genetically with pall.
Taken together, these data establish
a role for ubiquitin-dependent protea-
some degradation in the clearance of
apoptotic cells.
The link between phagocytosis and
proteasome function is poorly known
at present. Inmammals, a transient as-
sociation between the proteasome
and phagosomes has been reported
in macrophages and is thought to be
involved in the process of crosspre-
sentation of exogenous antigens by
class I MHC (Houde et al., 2003). How-
ever, this association is unlikely to be
required for phagocytosis itself. Inter-
estingly, proteasome subunits have
been identified in phagosomes con-
taining a latex bead by a proteomics
approach in Drosophila (Stuart et al.,
2007). Yet, these proteins did not ap-
pear to be necessary for the phagocy-
tosis of Staphyloccocus aureus or
Escherichia coli in a cell culture model.
Genome-wideRNAiscreenshavebeen
performed in Drosophila cell culture to
identify the genes that affect infection
by the intracellular pathogens Listeria
monocytogenes and MycobacteriumFigure 1. Model of Apoptotic Cell Clearance in D. melanogaster
The ubiquitin-proteasome systemmay control the stability of an inhibitor, X, that may regulate one
ormultiple steps required for efficient engulfment of apoptotic cells. See text for further discussion.
CQM, Croquemort; DRP, Draper; Ub, ubiquitin.fortuitum (Ayres and Schneider, 2006,
and references therein). These screens
failed to reveal a role for SCF and the
proteasome in controlling these infec-
tions, with the exception of the protea-
some being necessary to limit the nox-
ious effects of listeriolysin on the host
cell. Thus, the ubiquitin-proteasome
system appears to be required only
for the clearance of apoptotic cells, or
large particles, although further exper-
imental evidence is required to confirm
this conclusion.
In mammals, ubiquitylation and pro-
teasomal function is required for the
formation of an acidic intraphagoso-
mal multivesicular compartment that
may play a role in clearing the FcgRII
receptor from the limiting membrane
of the phagosome (Lee et al., 2005).
Nevertheless, fusion of the phago-
some to lysosomes proceeds normally
when proteasomal function is im-
paired. Thus, itmaybeworth determin-
ing whether Croquemort or Draper are
targeted by the PALL-SCF complex to
regulate the stability and phagocytic
activity of these apoptotic cell recep-
tors.Immunity 2Having potentially ruled out a role for
the proteasome in the basic mecha-
nisms of phagocytosis, it is conceiv-
able that the SCF-proteasome axis
controls the half-life of an inhibitor tar-
geting a specific step of phagocytosis
(Figure 1). Indeed, such inhibitors have
been identified in Drosophila (Stuart
et al., 2007). What could be this step?
pall mutant macrophages are able to
degrade apoptotic corpses almost
completely. They contain an average
of one apoptotic corpse. These obser-
vations suggest that phagocytosis is
able to proceed to completion, but
much less efficiently. It could be that
a partially redundant mechanism com-
pensates a defective PALL-SCF com-
plex. Alternatively, apoptotic corpses
are large particles that likely require
massive membrane trafficking for the
extension of pseudopods and the for-
mation of the phagosome membrane.
This may be a step that limits the effi-
ciency of engulfment and that could
be finely regulated by a degradable
inhibitor. However, neither the PALL-
SCF nor the proteasome were appar-
ently required for the uptake of yeasts7, October 2007 ª2007 Elsevier Inc. 543
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et al., 2006), suggesting that size of the
engulfed particle may not be the rele-
vant parameter that distinguishes en-
gulfment of corpses from other forms
of phagocytosis. Thus, the determina-
tion of the processs regulated by the
PALL-SCF complex is a priority for fur-
ther investigations. Importantly, it will
be interesting to determine whether
SCF complexes and the proteasome
are required for the clearance of apo-
ptotic cells in amoebes, nematodes,
and mammals.Dendritic Cells B
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Typically, dendritic cells (DCs) in
inflammation or infection. In this is
interactions as a unique maturati
The induction of an efficient and pro-
tective immune response depends on
the interaction between naive antigen-
specific T cells and professional anti-
gen-presenting cells (APCs). Because
of their unique features, such asmigra-
tory capacity and expression of costi-
mulatory molecules, dendritic cells
(DCs) are considered the prototypic
professional APCs. DCs are present as
sentinels in peripheral tissues, where
they capture antigens that may be pre-
sented to CD4+ and CD8+ T cells. DCs
undergo a maturation process after
sensing pathogen-derived structures
through pattern recognition receptors
such as Toll-like receptors (TLRs), ex-
posure to proinflammatory cytokines,
or after ligation of the surface receptor
CD40. Uponmaturation, DCs stop tak-
ing up antigens, change their pattern
of homing receptors (e.g., upregulation
of CCR7; Roake et al., 1995), which
allows them to migrate into the T cell
544 Immunity 27, October 2007 ª2007 EREFERENCES
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on pathway by which DCs are cap
areas of secondary lymphoid organs,
and upregulate costimulatory mole-
cules such as CD86. These changes
enable efficient priming of naive anti-
gen-specific T cells.
Under steady state, most DCs in
peripheral tissues have an immature
phenotype. They efficiently take up
antigens but lack high expression of
costimulatory molecules and CCR7
and thus can’t productively activate
naive T cells to develop into effectors.
Rather, it was thought that the interac-
tion of naive T cells with immature DCs
results in the induction of peripheral
T cell tolerance (Probst et al., 2005;
Steinman et al., 2003) in a T cell-intrin-
sic (e.g., anergy, deletion) or -extrinsic
(e.g., via T regulatory [Treg] cells or
cytokines) fashion (Probst et al., 2005;
Sakaguchi,2004;Steinmanetal., 2003).
The contact between naive T cells and
DCs is thought to take place in T cell
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which requires the DCs in the peri-
pheral tissues tomove there. However,
althoughmature DCs with upregulated
expression of CCR7 could migrate
to the secondary lymphoid organs
(Roake et al., 1995), how immature
DCs reach these organs is less clear.
Langerhans cells (LCs), a subset of
DCs that reside in mucosal epithelia
and epidermis, form a 3-dimensional
network and adhere to surrounding
keratinocytes through the homophilic
adhesion molecule E-cadherin. It has
been shown that LCs migrate into the
cutaneous lymph nodes under steady-
state conditions, albeit much slower
than after mechanical trauma (Kis-
senpfennig et al., 2005). Along the
same line, E-cadherin was found to
be markedly downregulated on LCs
upon theirmaturation,whichmayallow
LCs to more efficiently leave the epi-
dermis and migrate into cutaneous
lymph nodes, where they (in)directly
